Related search

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

Oncology Letters
Cancer ResearchOncology
2010English

ILD During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Real-World Effectiveness and Safety of Nivolumab in Patients With Non-Small Cell Lung Cancer: A Multicenter Retrospective Observational Study in Japan

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

Oncology Letters
Cancer ResearchOncology
2014English

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Chinese Perspectives on Clinical Efficacy and Safety of Alectinib in Patients With ALK-positive Advanced Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Clinical Efficacy and Safety of Afatinib in the Treatment of Non-Small-Cell Lung Cancer in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib Concurrent With Thoracic Radiotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Cost-Effectiveness of First-Line Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer Unsuitable for Chemotherapy

BMJ Open
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy